Brevan Howard Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.5K | Sell |
81,843
-163,774
| -67% | -$185K | ﹤0.01% | 1699 |
|
|
2025
Q1 | $359K | Buy |
245,617
+158,044
| +180% | +$231K | ﹤0.01% | 765 |
|
|
2024
Q4 | $187K | Buy |
87,573
+24,515
| +39% | +$52.2K | ﹤0.01% | 890 |
|
|
2024
Q3 | $177K | Buy |
63,058
+3,353
| +6% | +$9.39K | ﹤0.01% | 958 |
|
|
2024
Q2 | $139K | Buy |
59,705
+27,519
| +85% | +$64.1K | ﹤0.01% | 891 |
|
|
2024
Q1 | $144K | Sell |
32,186
-65,934
| -67% | -$295K | ﹤0.01% | 805 |
|
|
2023
Q4 | $315K | Buy |
98,120
+79,743
| +434% | +$256K | ﹤0.01% | 649 |
|
|
2023
Q3 | $58.3K | Buy |
+18,377
| New | +$58.3K | ﹤0.01% | 303 |
|